国际口腔医学杂志 ›› 2017, Vol. 44 ›› Issue (5): 514-518.doi: 10.7518/gjkq.2017.05.004
李琳1, 2, 王丹1, 赵曼竹3, 唐明1
Li Lin1, 2, Wang Dan1, Zhao Manzhu3, Tang Ming1
摘要: 神经退行性疾病包括阿兹海默病、帕金森病、亨廷顿氏病等,主要表现为患者渐进性运动、感觉或认知功能障碍,该类疾病多发生于中老年人,且无有效的治愈措施。诸多研究表明,中枢神经炎症、全身炎症及免疫失调可能参与该类疾病的发生与发展。慢性牙周炎作为局部细菌感染性疾病,可能通过牙周致病菌及炎症介质等方式调节机体,影响神经退行性疾病。本文就目前慢性牙周炎与神经退行性疾病的相关性研究作一综述,旨在为预防和治疗神经退行性疾病提供新的思路。
中图分类号:
[1] Mulak A, Bonaz B. Brain-gut-microbiota axis in Par-kinson’s disease[J]. World J Gastroenterol, 2015, 21 (37):10609-10620. [2] Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response [J]. Trends Immunol, 2014, 35(1):3-11. [3] Ide M, Harris M, Stevens A, et al. Periodontitis and cognitive decline in Alzheimer’s disease[J]. PLoS One, 2016, 11(3):e0151081. [4] Joseph BK, Kullman L, Sharma PN. The oral-systemic disease connection: a retrospective study[J]. Clin Oral Investig, 2016, 20(8):2267-2273. [5] Chapple IL, Milward MR, Dietrich T. The prevalence of inflammatory periodontitis is negatively associated with serum antioxidant concentrations[J]. J Nutr, 2007, 137(3):657-664. [6] 齐小秋. 第三次全国口腔健康流行病学调查报告[M]. 北京: 人民卫生出版社, 2008:60-102. Qi XQ. The third national oral health epidemiologi-cal survey report[M]. Beijing: People’s Medical Pub-lishing House, 2008:60-102. [7] Hollister EB, Gao C, Versalovic J. Compositional and functional features of the gastrointestinal microbiome and their effects on human health[J]. Gastroentero-logy, 2014, 146(6):1449-1458. [8] Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation[J]. Nat Rev Im-munol, 2015, 15(1):30-44. [9] Socransky SS, Haffajee AD. Dental biofilms: difficult therapeutic targets[J]. Periodontol 2000, 2002, 28: 12-55. [10] Bensley L, VanEenwyk J, Ossiander EM. Associations of self-reported periodontal disease with metabolic syndrome and number of self-reported chronic con-ditions[J]. Prev Chronic Dis, 2011, 8(3):A50. [11] Dye BA, Herrera-Abreu M, Lerche-Sehm J, et al. Serum antibodies to periodontal bacteria as diagnostic markers of periodontitis[J]. J Periodontol, 2009, 80 (4):634-647. [12] Wu Z, Nakanishi H. Connection between periodonti-tis and Alzheimer’s disease: possible roles of micro-glia and leptomeningeal cells[J]. J Pharmacol Sci, 2014, 126(1):8-13. [13] Kamer AR, Craig RG, Dasanayake AP, et al. Inflam-mation and Alzheimer’s disease: possible role of perio-dontal diseases[J]. Alzheimers Dement, 2008, 4(4): 242-250. [14] Belstrøm D, Holmstrup P, Damgaard C, et al. The atherogenic bacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythro-cytes[J]. Infect Immun, 2011, 79(4):1559-1565. [15] Lakio L, Antinheimo J, Paju S, et al. Tracking of plasma antibodies against Aggregatibacter actinomy-cetemcomitans and Porphyromonas gingivalis during 15 years[J]. J Oral Microbiol, 2009, 1:10.3402/jom.-v1i0.1979. [16] Poole S, Singhrao SK, Kesavalu L, et al. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue[J]. J Alzheimers Dis, 2013, 36(4):665-677. [17] Tomás I, Alvarez M, Limeres J, et al. Prevalence, du-ration and aetiology of bacteraemia following dental extractions[J]. Oral Dis, 2007, 13(1):56-62. [18] Forner L, Larsen T, Kilian M, et al. Incidence of ba-cteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation[J]. J Clin Periodontol, 2006, 33(6):401-407. [19] Ferrari CC, Tarelli R. Parkinson’s disease and systemic inflammation[J]. Parkinsons Dis, 2011, 2011:436813. [20] Liu Y, Wu Z, Zhang X, et al. Leptomeningeal cells transduce peripheral macrophages inflammatory sig-nal to microglia in reponse to Porphyromonas gingi-valis LPS[J]. Mediators Inflamm, 2013, 2013:407562. [21] Appel SH, Beers DR, Henkel JS. T cell-microglial dialogue in Parkinson’s disease and amyotrophic lateral sclerosis: are we listening[J]. Trends Immunol, 2010, 31(1):7-17. [22] Beers DR, Zhao W, Liao B, et al. Neuroinflammation modulates distinct regional and temporal clinical res-ponses in ALS mice[J]. Brain Behav Immun, 2011, 25(5):1025-1035. [23] Lee JW, Lee YK, Yuk DY, et al. Neuro-inflammation induced by lipopolysaccharide causes cognitive im-pairment through enhancement of beta-amyloid ge-neration[J]. J Neuroinflammation, 2008, 5:37. [24] Püntener U, Booth SG, Perry VH, et al. Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia[J]. J Neuroinflammation, 2012, 9:146. [25] Montgomery SL, Bowers WJ. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degene-rative processes within the central nervous system[J]. J Neuroimmune Pharmacol, 2012, 7(1):42-59. [26] Bhaskar K, Maphis N, Xu G, et al. Microglial derived tumor necrosis factor-α drives Alzheimer’s disease-related neuronal cell cycle events[J]. Neurobiol Dis, 2014, 62:273-285. [27] Sparks Stein P, Steffen MJ, Smith C, et al. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer’s disease[J]. Alzheimers Dement, 2012, 8(3):196-203. [28] Riviere GR, Riviere KH, Smith KS. Molecular and immunological evidence of oral Treponema in the hu-man brain and their association with Alzheimer’s disease [J]. Oral Microbiol Immunol, 2002, 17(2):113-118. [29] Noble JM, Scarmeas N, Celenti RS, et al. Serum IgG antibody levels to periodontal microbiota are asso-ciated with incident Alzheimer disease[J]. PLoS One, 2014, 9(12):e114959. [30] Farhad SZ, Amini S, Khalilian A, et al. The effect of chronic periodontitis on serum levels of tumor necro-sis factor-alpha in Alzheimer disease[J]. Dent Res J (Isfahan), 2014, 11(5):549-552. [31] Gil-Montoya JA, Sanchez-Lara I, Carnero-Pardo C, et al. Is periodontitis a risk factor for cognitive im-pairment and dementia? A case-control study[J]. J Periodontol, 2015, 86(2):244-253. [32] Engelborghs S, Gilles C, Ivanoiu A, et al. Rationale and clinical data supporting nutritional intervention in Alzheimer’s disease[J]. Acta ClinBelg, 2014, 69(1): 17-24. [33] Noble JM, Borrell LN, Papapanou PN, et al. Perio-dontitis is associated with cognitive impairment among older adults: analysis of NHANES-Ⅲ[J]. J Neurol Neurosurg Psychiatry, 2009, 80(11):1206-1211. [34] Einarsdóttir ER, Gunnsteinsdóttir H, Hallsdóttir MH, et al. Dental health of patients with Parkinson’s dis-ease in Iceland[J]. Spec Care Dentist, 2009, 29(3): 123-127. [35] Herrera AJ, Castaño A, Venero JL, et al. The single intranigral injection of LPS as a new model for stu-dying the selective effects of inflammatory reactions on dopaminergic system[J]. Neurobiol Dis, 2000, 7 (4):429-447. [36] Chen H, Zhang SM, Hernán MA, et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease[J]. Arch Neurol, 2003, 60(8):1059-1064. |
[1] | 王晓宇,朱昭蓉,吴亚菲,赵蕾. 中性粒细胞细胞外陷阱网与牙周炎的相关性研究进展[J]. 国际口腔医学杂志, 2020, 47(3): 304-310. |
[2] | 周婕妤,刘琳,吴亚菲,赵蕾. 微小RNA介导的牙周炎与动脉粥样硬化相关机制的研究进展[J]. 国际口腔医学杂志, 2020, 47(1): 76-83. |
[3] | 文书琼,郭君怡,戴文晓,王迪侃,王智. 白色念珠菌影响口腔黏膜癌变的机制进展[J]. 国际口腔医学杂志, 2019, 46(6): 705-710. |
[4] | 原振英,管翠强,南欣荣. DNA甲基化与口腔疾病的研究进展[J]. 国际口腔医学杂志, 2019, 46(4): 437-441. |
[5] | 朱博文,陈立妹,郭竹玲. NLRP3炎性小体在牙周疾病中的研究进展[J]. 国际口腔医学杂志, 2019, 46(4): 450-455. |
[6] | 王鹞,吕慧欣,杜留熠,顾芯铭,任静宜,于维先,周延民. 软脑膜在外周炎症影响神经炎症过程中的作用[J]. 国际口腔医学杂志, 2019, 46(2): 223-227. |
[7] | 刘芳,蔡扬. 白细胞介素-35及其与口腔疾病的关系[J]. 国际口腔医学杂志, 2018, 45(6): 716-722. |
[8] | 毛璐,鞠侯雨,任国欣. 程序性细胞死亡受体-1与其配体信号通路的调控及其在头颈鳞状细胞癌治疗中的研究进展[J]. 国际口腔医学杂志, 2018, 45(5): 560-565. |
[9] | 余芯乐, 郑军, 徐江, 曾妍. 口腔鳞状细胞癌患者唾液和血清中N-α-乙酰基转移酶10的水平及其临床意义[J]. 国际口腔医学杂志, 2018, 45(4): 391-395. |
[10] | 黄海霞, 兰玉燕, 张昊, 潘兰兰, 郭玲, 刘敏. 慢性牙周炎患者种植修复后种植体牙周指数及龈沟液炎性因子水平的变化研究[J]. 国际口腔医学杂志, 2018, 45(4): 396-402. |
[11] | 李一涵, 潘兰兰. 牙周病与阿尔兹海默症的关系[J]. 国际口腔医学杂志, 2018, 45(3): 335-339. |
[12] | 张湘宜, 刘亚丽. 牙源性干细胞的免疫调节作用[J]. 国际口腔医学杂志, 2018, 45(3): 276-279. |
[13] | 孟文霞, 蒋李懿, 赖艳群, 姚艳梅. 1例艾滋病非典型表现引发的思考[J]. 国际口腔医学杂志, 2018, 45(2): 132-134. |
[14] | 姚懿桓, 王冏珂, 赵奎, 时玉洁, 曾昕, 陈谦明. 天疱疮的免疫抑制剂治疗方法[J]. 国际口腔医学杂志, 2018, 45(2): 155-161. |
[15] | 李格格, 潘佳慧, 唐秋玲, 刘歆婵, 侯玉帛, 于维先. 牙龈素促进牙龈卟啉单胞菌免疫逃逸的机制[J]. 国际口腔医学杂志, 2017, 44(5): 519-522. |
|